approval
saveOZURDEX (DEXAMETHASONE) — FDA approval
community read0 votes
Sponsor: ABBVIE. Form: IMPLANT. Route: INTRAVITREAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalOZURDEX (DEXAMETHASONE) — FDA approvalMar 11, 2026 · 207d ago
- approvalOZURDEX (DEXAMETHASONE) — FDA approvalDec 19, 2022 · 1385d ago
- approvalOZURDEX (DEXAMETHASONE) — FDA approvalOct 21, 2020 · 2174d ago
- approvalOZURDEX (DEXAMETHASONE) — FDA approvalMay 15, 2018 · 3064d ago
- approvalOZURDEX (DEXAMETHASONE) — FDA approvalSep 26, 2014 · 4391d ago
- approvalOZURDEX (DEXAMETHASONE) — FDA approvalJun 28, 2014 · 4481d ago
- approvalOZURDEX (DEXAMETHASONE) — FDA approvalFeb 7, 2014 · 4622d ago
- approvalOZURDEX (DEXAMETHASONE) — FDA approvalSep 7, 2012 · 5140d ago
same company · ±60 days · 6
- approvalIMBRUVICA (IBRUTINIB) — FDA approvalFeb 8, 2016
- approvalcarbidopa: DUOPA (CARBIDOPA) — FDA approvalJan 26, 2016
- approvaldivalproex sodium DR: DEPAKOTE ER (DIVALPROEX SODIUM) — FDA approvalFeb 18, 2016
- approvaldivalproex sodium DR: DEPAKOTE (DIVALPROEX SODIUM) — FDA approvalFeb 18, 2016
- approvaldivalproex sodium DR: DEPAKOTE (DIVALPROEX SODIUM) — FDA approvalFeb 18, 2016
- approvalIMBRUVICA (IBRUTINIB) — FDA approvalMar 4, 2016
comments(0)
5-min edit window · permanent after that